Page last updated: 2024-10-29

iofetamine and Hepatic Encephalopathy

iofetamine has been researched along with Hepatic Encephalopathy in 1 studies

Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shiomi, S1
Kuroki, T1
Miyazawa, Y1
Ueda, T1
Takeda, T1
Nishiguchi, S1
Nakajima, S1
Kobayashi, K1
Ochi, H1

Trials

1 trial available for iofetamine and Hepatic Encephalopathy

ArticleYear
Evaluation of portal circulation through the superior mesenteric vein with an enteric capsule of [123I]iodoamphetamine.
    Journal of gastroenterology, 1995, Volume: 30, Issue:1

    Topics: Administration, Oral; Amphetamines; Capsules; Chronic Disease; Hepatic Encephalopathy; Hepatitis; Hu

1995